4.6 Article

Re-Ranking Sequencing Variants in the Post-GWAS Era for Accurate Causal Variant Identification

Journal

PLOS GENETICS
Volume 9, Issue 8, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pgen.1003609

Keywords

-

Funding

  1. Canadian Institutes of Health Research [CIHR MOP-84287, MDR-88001]
  2. Natural Sciences and Engineering Research Council of Canada [NSERC 250053-2008]
  3. CIHR Training Grant [GET-101831]
  4. National Institutes of Health Interdisciplinary Research Training in Biostatistics and Computational Biology Grant [T32-GM074897]
  5. Canada Foundation for Innovation under the auspices of Compute Canada
  6. Government of Ontario
  7. Ontario Research Fund-Research Excellence
  8. University of Toronto
  9. Wellcome Trust [076113]
  10. U.S. National Institutes of Health, National Cancer Institute [U01-CA98233, U01-CA98710, U01-CA98216]

Ask authors/readers for more resources

Next generation sequencing has dramatically increased our ability to localize disease-causing variants by providing base-pair level information at costs increasingly feasible for the large sample sizes required to detect complex-trait associations. Yet, identification of causal variants within an established region of association remains a challenge. Counter-intuitively, certain factors that increase power to detect an associated region can decrease power to localize the causal variant. First, combining GWAS with imputation or low coverage sequencing to achieve the large sample sizes required for high power can have the unintended effect of producing differential genotyping error among SNPs. This tends to bias the relative evidence for association toward better genotyped SNPs. Second, re-use of GWAS data for fine-mapping exploits previous findings to ensure genome-wide significance in GWAS-associated regions. However, using GWAS findings to inform fine-mapping analysis can bias evidence away from the causal SNP toward the tag SNP and SNPs in high LD with the tag. Together these factors can reduce power to localize the causal SNP by more than half. Other strategies commonly employed to increase power to detect association, namely increasing sample size and using higher density genotyping arrays, can, in certain common scenarios, actually exacerbate these effects and further decrease power to localize causal variants. We develop a re-ranking procedure that accounts for these adverse effects and substantially improves the accuracy of causal SNP identification, often doubling the probability that the causal SNP is top-ranked. Application to the NCI BPC3 aggressive prostate cancer GWAS with imputation meta-analysis identified a new top SNP at 2 of 3 associated loci and several additional possible causal SNPs at these loci that may have otherwise been overlooked. This method is simple to implement using R scripts provided on the author's website.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available